Abstract
Diabetic nephropathy is presently the first reason of end stage renal failure in Europe and the USA and its worldwide prevalence is rapidly increasing. Several studies have demonstrated that diabetes per se is not sufficient to induce nephropathy and a genetic predisposition has to be present as well. Looking for genetic markers, investigators have been helped by the finding that a predisposition to hypertension facilitates the development of nephropathy in diabetic patients. Prompted by the evidence that essential hypertension is characterized by a number of defects at cellular level, similar dysfunctions have been searched also in cells obtained from diabetic patients with nephropathy. Increased Na-Li countertransport and Na-H exchange activities, slower Ca pump and faster cell proliferation rate have been found in cells obtained from patients affected by diabetic nephropathy. The definition of these intermediate phenotypes represents a necessary step toward the identification of the molecular dysfunction(s) underlying the development of diabetic nephropathy. The present review will focus on the description of the different cell dysfunctions identified in patients affected by diabetic nephropathy, their pathophysiologic meaning and will try to define an unifying hypothesis that, by linking together the different dysfunctions, will highlight a few areas "at risk", candidate to home the primitive genetic abnormality.
Keywords: Diabetic nephropathy, Na-Li countertransport, Na-H exchange, Ca pump, Cell proliferation rate, Cell matrix
Current Diabetes Reviews
Title: Dysfunction of Cellular Transporters and Predisposition to Diabetic Nephropathy
Volume: 2 Issue: 2
Author(s): Gianpaolo Zerbini, Daniela Gabellini, Dora Ruggieri and Anna Maestroni
Affiliation:
Keywords: Diabetic nephropathy, Na-Li countertransport, Na-H exchange, Ca pump, Cell proliferation rate, Cell matrix
Abstract: Diabetic nephropathy is presently the first reason of end stage renal failure in Europe and the USA and its worldwide prevalence is rapidly increasing. Several studies have demonstrated that diabetes per se is not sufficient to induce nephropathy and a genetic predisposition has to be present as well. Looking for genetic markers, investigators have been helped by the finding that a predisposition to hypertension facilitates the development of nephropathy in diabetic patients. Prompted by the evidence that essential hypertension is characterized by a number of defects at cellular level, similar dysfunctions have been searched also in cells obtained from diabetic patients with nephropathy. Increased Na-Li countertransport and Na-H exchange activities, slower Ca pump and faster cell proliferation rate have been found in cells obtained from patients affected by diabetic nephropathy. The definition of these intermediate phenotypes represents a necessary step toward the identification of the molecular dysfunction(s) underlying the development of diabetic nephropathy. The present review will focus on the description of the different cell dysfunctions identified in patients affected by diabetic nephropathy, their pathophysiologic meaning and will try to define an unifying hypothesis that, by linking together the different dysfunctions, will highlight a few areas "at risk", candidate to home the primitive genetic abnormality.
Export Options
About this article
Cite this article as:
Zerbini Gianpaolo, Gabellini Daniela, Ruggieri Dora and Maestroni Anna, Dysfunction of Cellular Transporters and Predisposition to Diabetic Nephropathy, Current Diabetes Reviews 2006; 2 (2) . https://dx.doi.org/10.2174/157339906776818550
DOI https://dx.doi.org/10.2174/157339906776818550 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A New Risk Chart of Acute Myocardial Infarction in Men by an Innovative Algorithm: A Pilot Study
Current Pharmacogenomics and Personalized Medicine Dual Role of Heat Shock Proteins (HSPs) in Anti-Tumor Immunity
Current Molecular Medicine The Discovery and Development of Drug Combinations for the Treatment of Various Diseases from Patent Literature (1980-Present)
Current Topics in Medicinal Chemistry Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women
Recent Patents on Anti-Cancer Drug Discovery The Role of the Immune System in the Pathogenesis of Hypertension
Current Hypertension Reviews Arterial Stiffness:A Potential Therapeutic Target to Reduce Cardiovascular Mortality
Current Hypertension Reviews Pharmacological Modulations of the Renin-Angiotensin-Aldosterone System in Human Congestive Heart Failure: Effects on Peripheral Vascular Endothelial Function
Current Vascular Pharmacology Potential Approaches to Enhance the Effects of Estrogen on Senescent Blood Vessels and Postmenopausal Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Inflammation in Atherosclerosis: A New Therapeutic Target
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer
Current Drug Targets Serotonin Reuptake Inhibitors and Cardiovascular Disease
Vascular Disease Prevention (Discontinued) The Endothelin Axis: A Novel Target for Pharmacotherapy of Female Malignancies
Current Vascular Pharmacology Anti-Inflammatory Effects of Fibrates: An Overview
Current Medicinal Chemistry Kinetic Spectrophotometric Determination of Betaxolol, Clopidogrel and Imidapril in Pharmaceutical Preparations
Current Analytical Chemistry Heat Shock Paradox and a New Role of Heat Shock Proteins and their Receptors as Anti-Inflammation Targets
Inflammation & Allergy - Drug Targets (Discontinued) Clinical Pharmacotherapy and Drug Development for Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications
Recent Patents on Cardiovascular Drug Discovery Investigation on the Development of Losartan Potassium Sustained Release Microspheres by Solvent Evaporation Methods
Micro and Nanosystems Sleep Apnea and Coronary Heart Disease: From Dusk Till Dawn and Further
Current Respiratory Medicine Reviews Effects of Cyclosporine A and Itraconazole on Permeability, Biliary Excretion and Pharmacokinetics of Amlidipine
Drug Metabolism Letters